Abstract:Of the more than 100 types of brain cancer, glioblastoma (GBM) is the deadliest. As GBM stem cells (GSCs) are considered to be responsible for therapeutic resistance and tumor recurrence, effective targeting and elimination of GSCs could hold promise for preventing GBM recurrence and achieving potential cures. We show here that SUV39H1, which encodes a histone-3, lysine-9 methyltransferase, plays a critical role in GSC maintenance and GBM progression. Upregulation of SUV39H1 was observed in GBM samples compared to normal brain tissues, and knockdown of SUV39H1 in patient-derived GSCs impaired their proliferation and stemness. Single-cell RNA-seq analysis demonstrated restricted expression of SUV39H1 is in GSCs relative to non-stem GBM cells, likely due to super-enhancer-mediated transcriptional activation, while whole cell RNA-seq analysis revealed that SUV39H1 regulates G2/M cell cycle progression, stem cell maintenance, and cell death pathways in GSCs. By integrating the RNA-seq data with ATAC-seq (assay for transposase-accessible chromatin followed by sequencing), we further demonstrated altered chromatin accessibility in key genes associated with these pathways following SUV39H1 knockdown. Treatment with chaetocin, a SUV39H1 inhibitor, mimicked the functional effects of SUV39H1 knockdown in GSCs and sensitized GSCs to the GBM chemotherapy drug temozolomide. Furthermore, targeting SUV39H1 in vivo using a patient-derived xenograft model for GBM inhibited GSC-driven tumor formation. This is the first report demonstrating a critical role for SUV39H1 in GSC maintenance. SUV39H1-mediated targeting of GSCs could enhance the efficacy of existing chemotherapy, presenting a promising strategy for improving GBM treatment and patient outcomes.

Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination

SC-08 * TRANSCRIPTIONAL AND POST-TRANSLATIONAL REGULATIONS OF C-Myc IN GLIOBLASTOMA STEM CELLS

RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation

Loss of Deubiquitylase USP2 Triggers Development of Glioblastoma Via TGF-β Signaling.

USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells

USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1

Ubiquitin-specific Protease 22 Acts As an Oncoprotein to Maintain Glioma Malignancy Through Deubiquitinating B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 for Stabilization.

Lactylation-driven USP4-mediated ANXA2 Stabilization and Activation Promotes Maintenance and Radioresistance of Glioblastoma Stem Cells

Deubiquitinase USP9X Deubiquitinates Β-Catenin and Promotes High Grade Glioma Cell Growth

Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer

Nuclear GSK3β Promotes Tumorigenesis by Phosphorylating KDM1A and Inducing Its Deubiquitylation by USP22

The Zinc Finger Transcription Factor Zfx is Required for Maintaining the Tumorigenic Potential of Glioblastoma Stem Cells

The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer.

STEM-43. GSK3β PROMOTES THE BMX-MEDIATED STAT3 ACTIVATION TO MAINTAIN GLIOBLASTOMA STEM CELLS

Deubiquitinase PSMD14 promotes tumorigenicity of glioblastoma by deubiquitinating and stabilizing β‐catenin

SUV39H1 Preserves Cancer Stem Cell Chromatin State and Properties in Glioblastoma

Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis

β2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages

USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma

USP13 Deubiquitinates and Stabilizes Cyclin D1 to Promote Gastric Cancer Cell Cycle Progression and Cell Proliferation